Internal Medicine, Infectious Disease · Oakland, CA
NPI
1417375940
Since 2014
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
12
Medicare group memberships
Hospitals
2
Hospital affiliations
3100 Summit St, 2nd Floor
Oakland, CA, 94609
Phone (510) 869-8400
Groups this clinician bills Medicare through
Medicare paid, 2024
$3,087
42 services
Medicare patients, 2024
32
Average age 74
Drug cost, 2024
$2.0M
1,038 prescriptions
Company payments, 2023
$246
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Nupur Gupta was code G0408 (follow-up inpatient consultation, complex, physicians typically spend 35 minutes communicating with the patient via telehealth), 11 times for 11 patients. In total Nupur Gupta billed 42 services in 12 codes, and Medicare paid $3,087.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-05-20.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| G0408 Follow-up inpatient consultation, complex, physicians typically spend 35 minutes communicating with the patient via telehealth | Office | 11 | 11 | $81.84 | $900 |
By year: 2022 $9,656 for 151 services; 2023 $7,640 for 115 services; 2024 $3,087 for 42 services.
Medicare prescription drug claims, 2024
In 2024, the drug Nupur Gupta prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 220 prescriptions and refills. In total Nupur Gupta wrote 1,038 Medicare prescriptions that cost $2.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 220 | 226 | 29 | $832K |
| Tivicay Dolutegravir Sodium | 95 | 95 | Under 11 | $288K |
| Descovy Emtricitabine/Tenofov Alafenam | 43 | 43 | Under 11 | $88K |
| Odefsey Emtricitab/Rilpiviri/Tenof Ala | 37 | 37 | Under 11 | $127K |
| Pifeltro Doravirine | 34 | 34 | Under 11 | $58K |
| Juluca Dolutegravir/Rilpivirine | 32 | 32 | Under 11 | $116K |
| Lamivudine-Zidovudine Lamivudine/Zidovudine | 28 | 38 | Under 11 | $16K |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 28 | 28 | Under 11 | $331 |
| Efavirenz Generic | 27 | 27 | Under 11 | $14K |
| Genvoya Elviteg/Cob/Emtri/Tenof Alafen | 25 | 25 | Under 11 | $95K |
| Azithromycin Generic | 21 | 21 | Under 11 | $400 |
| Gabapentin Generic | 18 | 20 | Under 11 | $179 |
| Rosuvastatin Calcium Generic | 16 | 20 | Under 11 | $80.51 |
| Ritonavir Generic | 16 | 22 | Under 11 | $4,936 |
| Doxycycline Hyclate Generic | 16 | 26 | Under 11 | $156 |
Brand drugs: 601 claims; generic drugs: - claims.
Money and other things of value reported by the companies
In 2023, drug and medical device companies paid Nupur Gupta $246 ($246 in general payments such as food, travel and fees) from 2 companies. The largest payer was NuVasive, Inc. with $136.
| Company | Payments | Amount |
|---|---|---|
| NuVasive, Inc. GMED | 1 | $136 |
| KLS-Martin L.P. | 1 | $110 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.